Posted on Leave a comment

Functional Dyspepsia Market to Exhibit Substantial Growth During the Forecast Period (2019- 2032) | Key Companies -Zeria Pharma, RaQualia Pharma, ISOThrive, and Jiangxi Qingfeng Pharma

Functional Dyspepsia Market to Exhibit Substantial Growth During the Forecast Period (2019- 2032) | Key Companies -Zeria Pharma, RaQualia Pharma, ISOThrive, and Jiangxi Qingfeng Pharma
Delveinsight Business Research LLP

DelveInsight’s “Functional Dyspepsia Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Functional Dyspepsia Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Functional Dyspepsia market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Functional Dyspepsia Market

Functional Dyspepsia: An Overview

Dyspepsia is a common symptom with an extensive differential diagnosis and heterogeneous pathophysiology. The majority of patients with symptoms of dyspepsia are eventually categorized as having functional (idiopathic, non-ulcer) dyspepsia (FD) means no obvious cause for the symptoms present. Functional Dyspepsia is one of the most common gastrointestinal disorders and imposes a social and economic burden worldwide.

Like other GI disorders, the treatment methods for Functional Dyspepsia depend on the severity of the disorder, which is determined by the intensity and constancy of the symptoms, the degree of psychosocial difficulties, and the frequency of need for health care assistance.

Functional Dyspepsia Market Key Facts

  • According to the article by Madisch et al. (2018), Functional Dyspepsia is one of the more common functional disorders, with a prevalence of 10–20%. It affects the gastrointestinal tract.

  • According to the article by Harer et al. (2020), The community prevalence of dyspepsia is typically quoted in the range of 20% to 40%, and the disorder accounts for 3% to 5% of primary care visits.

  • According to the article by Longstreth et al. (2019), approximately 25% of patients with dyspepsia have an underlying organic cause, and nearly 75% of patients have functional (idiopathic or non-ulcer) dyspepsia with no underlying cause on diagnostic evaluation.

Functional Dyspepsia Market

Functional Dyspepsia Market Size is anticipated to increase during the study period owing to the rise in the geriatric population and changing dietary habits in the 7MM.

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Functional Dyspepsia market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Functional Dyspepsia market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.

Functional Dyspepsia Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.

Functional Dyspepsia Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Functional Dyspepsia market or expected to get launched during the study period. The analysis covers Functional Dyspepsia market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Functional Dyspepsia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report –

Functional Dyspepsia Therapeutics Analysis

Limited late-stage pipeline activities have been observed in the Functional Dyspepsia therapeutics market, besides, most of the trials are either completed or suspended, or terminated. Still, some of the key players are active in the Functional Dyspepsia therapeutics domain. 

Some of the key companies in the Functional Dyspepsia Market Includes:

  • Zeria Pharmaceutical

  • RaQualia Pharma

  • ISOThrive

  • Jiangxi Qingfeng Pharmaceutical 

And many others. 

Functional Dyspepsia Therapies covered in the report include:

  • ISOT-101

  • Naronapride

  • RQ-00000010

  • Aolanti Weipang Tablets

And many more.

Get More Detailed Insights Into the Emerging Therapies & Key Companies –

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Functional Dyspepsia Competitive Intelligence Analysis

4. Functional Dyspepsia Market Overview at a Glance

5. Functional Dyspepsia Disease Background and Overview

6. Functional Dyspepsia Patient Journey

7. Functional Dyspepsia Epidemiology and Patient Population

8. Functional Dyspepsia Treatment Algorithm, Current Treatment, and Medical Practices

9. Functional Dyspepsia Unmet Needs

10. Key Endpoints of Functional Dyspepsia Treatment

11. Functional Dyspepsia Marketed Products

12. Functional Dyspepsia Emerging Therapies

13. Functional Dyspepsia Seven Major Market Analysis

14. Attribute Analysis

15. Functional Dyspepsia Market Outlook (7 major markets)

16. Functional Dyspepsia Access and Reimbursement Overview

17. KOL Views on the Functional Dyspepsia Market.

18. Functional Dyspepsia Market Drivers

19. Functional Dyspepsia Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report –

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.


Other Trending Reports by DelveInsight

Dense Deposit Disease Market
“Dense Deposit Disease Market” research report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Dense Deposit Disease market trends in 7MM.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States